Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-23T03:21:35.146Z Has data issue: false hasContentIssue false
  • English
  • Français

The impact of coronavirus disease 2019 on suspected head and neck cancer two-week-wait referrals

Part of: JLO Coronavirus Collection

Published online by Cambridge University Press:  23 June 2021

N Bhamra ,
B Gorman ,
W Arnold ,
A Rajah ,
K Jolly ,
H Nieto ,
J Fussey  and
L Liew
N Bhamra*
Affiliation:
Department of Otolaryngology, Royal Wolverhampton NHS Trust, Wolverhampton, UK
B Gorman
Affiliation:
Department of Otolaryngology, Royal Wolverhampton NHS Trust, Wolverhampton, UK
W Arnold
Affiliation:
Department of Otolaryngology, Royal Wolverhampton NHS Trust, Wolverhampton, UK
A Rajah
Affiliation:
Department of Otolaryngology, Dudley Group NHS Foundation Trust, Dudley, UK
K Jolly
Affiliation:
Department of Otolaryngology, Royal Wolverhampton NHS Trust, Wolverhampton, UK
H Nieto
Affiliation:
Department of Otolaryngology, Dudley Group NHS Foundation Trust, Dudley, UK
J Fussey
Affiliation:
Department of Otolaryngology, Royal Wolverhampton NHS Trust, Wolverhampton, UK
L Liew
Affiliation:
Department of Otolaryngology, Royal Wolverhampton NHS Trust, Wolverhampton, UK
*
Author for correspondence: Dr Navdeep Bhamra, Department of Otolaryngology, Royal Wolverhampton NHS Trust, WolverhamptonWV10 0QP, UK E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

The impact of coronavirus disease 2019 extends far beyond the immediate burden on healthcare systems caused by hospitalisation of patients with the disease itself.

Objective

To investigate the impact of the coronavirus disease 2019 pandemic on the referral rate of patients to the suspected head and neck cancer two-week-wait clinic.

Methods

A multicentre retrospective study was performed investigating data collected for all patients attending the suspected head and neck cancer two-week-wait clinic in ENT departments in the West Midlands.

Results

A total of 509 fast-track referrals were received from February to April in 2019, compared to 399 referrals in 2020. April 2020 saw a 62.4 per cent reduction in referral rate compared to April 2019.

Conclusion

The coronavirus disease 2019 pandemic has resulted in changes to health-seeking behaviours, and healthcare provision and delivery. Urgent policy interventions may be required to compensate for the hidden impact that the coronavirus disease 2019 pandemic has had on those with cancer.

Keywords

COVID-19CancerReferralsCOVID-19 Pandemic
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 136 , Issue 3 , March 2022 , pp. 248 - 251
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Dr N Bhamra takes responsibility for the integrity of the content of the paper

References

World Health Organization. Listings of WHO's response to COVID-19. In: https://www.who.int/news-room/detail/29-06-2020-covidtimeline [9 December 2020]Google Scholar
John Hopkins University of Medicine. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at John Hopkins University (JHU). In: https://coronavirus.jhu.edu/map.html [13 January 2021]Google Scholar
Ipsos MORI. The Health Foundation COVID-19 Survey. In: https://www.health.org.uk/sites/default/files/2020-06/Health%20Foundation%20COVID%2019%20Polling%20Health%20service%20usage.pdf [9 December 2020]Google Scholar
Office for National Statistics. Cancer registration statistics, England: 2017. In: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/2017 [9 December 2020]Google Scholar
National Institute for Health and Care Excellence. Head and neck cancers - recognition and referral. In: https://cks.nice.org.uk/topics/head-neck-cancers-recognition-referral/ [9 December 2020]Google Scholar
Cancer Research UK. Cancer waiting times definitions by country. In: https://www.cancerresearchuk.org/sites/default/files/cs_report_cwt.pdf [9 December 2020]Google Scholar
Kumar, R, Drinnan, M, Mehanna, H, Paleri, V. Efficacy of the two-week wait referral system for head and neck cancer: a systematic review. Ann R Coll Surg Engl (Suppl) 2012;94:102–6Google Scholar
Rimmer, J, Watson, J, O'Flynn, P, Vaz, F. A head and neck ‘two-week wait’ clinic: cancer referrals or the worried well? Ann R Coll Surg Engl (Suppl) 2012;94:1–410.1308/147363512X13311314196212CrossRefGoogle Scholar
Edge, SB, Compton, CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471–410.1245/s10434-010-0985-4CrossRefGoogle ScholarPubMed
Taylor, R, Omakobia, E, Sood, S, Glore, RJ. The impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study. J Laryngol Otol 2020;134:684–710.1017/S0022215120001735CrossRefGoogle ScholarPubMed
Bodkin, H. Cancer referrals down by 80 per cent in some areas as coronavirus fears keep patients from hospitals. The Telegraph 2020, April 15Google Scholar
BMA. The hidden impact of COVID-19 on patient care in the NHS in England. In: https://www.bma.org.uk/media/2841/the-hidden-impact-of-covid_web-pdf.pdf [9 December 2020]Google Scholar
Fleming, DM, Elliot, AJ. Lessons from 40 years’ surveillance of influenza in England and Wales. Epidemiol Infect 2008;136:866–7510.1017/S0950268807009910CrossRefGoogle ScholarPubMed
NHS. Redeploying your secondary care medical workforce safely. In: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/C0666_Redeploying-your-secondary-care-medical-workforce-safely-v-2_14July.pdf [9 December 2020]Google Scholar
National Institute for Health and Care Service. COVID-19 rapid guideline: delivery of systemic anticancer treatments. In: https://www.nice.org.uk/guidance/ng161/resources/covid19-rapid-guideline-delivery-of-systemic-anticancer-treatments-pdf-66141895710661 [9 December 2020]Google Scholar
Tikka, T, Kavanagh, K, Lowit, A, Jiafeng, P, Burns, H, Nixon, IJ et al. Head and neck cancer risk calculator (HaNC-RC) – V. 2. Adjustments and addition of symptoms and social history factors. Clin Otolaryngol 2020;45:380–810.1111/coa.13511CrossRefGoogle ScholarPubMed